U.S. Diversified Financial Stock News

Enphase Energy entered this report with a bruised share price over the past month and quarter, yet the stock jumped about 6.6% today. The market latched on to one thing above all else: profitability snapped back. Basic earnings per share moved from a small loss in Q1 to about US$0.27 in Q2, supported by a non GAAP gross margin near the high 40s and positive free cash flow. For a solar hardware stock that has been wrestling with weaker margins and volatile demand, that earnings rebound is the...

Manhattan Associates just gave investors a sentiment shock. The stock dropped about 6% today from roughly US$204 to around US$191 even though the company posted what management called record Q2 and first half results, with Q2 revenue of US$298m and adjusted operating margin of 34.9%. The emotional hit sits squarely on the short term price screen, while the earnings story rests on strong cloud growth and record bookings. For you as a shareholder or watcher, the key question is whether that...

Some Viking Therapeutics, Inc. ( NASDAQ:VKTX ) shareholders may be a little concerned to see that the President, Brian...

Alkami Technology, Inc. recently reported second-quarter 2026 results, with revenue rising to US$129.84 million and net loss narrowing to US$8.9 million, while also issuing higher full-year revenue guidance and expanding its Plaid integration to offer cleaner, broader account connectivity for financial institutions on its digital banking platform. A distinctive angle is how the embedded Plaid integration aims to simplify vendor management and data aggregation for Alkami’s bank and credit...

Crown Holdings, Inc. has already reported second-quarter 2026 results, with sales of US$3,668 million and net income of US$245 million, and its Board subsequently declared a US$0.35 per-share cash dividend payable on August 20, 2026, to shareholders of record as of August 6, 2026. The company also completed a sizeable share repurchase program totaling 12,446,379 shares for about US$1.21 billion, which, alongside higher earnings per share, highlights a combination of returning cash to...

NextDecade Corporation has reported its second-quarter 2026 results, with net loss widening to US$65.43 million and basic and diluted loss per share from continuing operations at US$0.25, compared with US$0.23 a year earlier. Over the first six months of 2026, the company’s net loss increased to US$201.83 million and loss per share rose to US$0.76, highlighting the cash burn and earnings pressure during its project build-out phase. With this widening loss as a backdrop, we will now examine...

DraftKings (DKNG) is back in focus as traders position around its August 6 earnings report, with recent estimate revisions and sector wide regulatory and expansion developments shaping expectations for the stock. See our latest analysis for DraftKings. DraftKings shares have been volatile, with the 7 day share price return up 7.53%, the year to date share price return down 31.16%, and the 1 year total shareholder return down 46.34%. This points to short term momentum building against a weaker...

Omnicell, Inc. has reported past second-quarter 2026 results showing revenue of US$312.21 million and net income of US$24.29 million, alongside stronger earnings per share and improved performance for the first half of the year compared with the prior period. The company also issued revenue guidance of US$301 million–US$307 million for the third quarter and US$1.23 billion–US$1.25 billion for full-year 2026, giving investors clearer visibility into its near-term growth trajectory. With...

Recently, commentary on US Foods Holding highlighted that analysts expect the company's EPS to grow 16.4% this year, supported by above-average financial growth, strong cash flow trends, and positive earnings estimate revisions, reinforcing a view of healthier fundamentals than many peers. This combination of robust projected earnings expansion and improving analyst expectations has renewed investor attention on how effectively US Foods can convert operational initiatives into sustained...

AGCO (AGCO) is back in focus after its latest quarterly report on July 30, 2026. Earnings and revenue missed analyst expectations and full year revenue guidance was reduced. See our latest analysis for AGCO. The latest results and cut to revenue guidance have weighed on sentiment toward AGCO, with the share price down 6.09% over the last day and the 90 day share price return lower by 4.01%. Even so, the year to date share price return of 9.76% and 1 year total shareholder return of 10.03%...

Kohl's recently announced that long-serving board member John E. Schlifske retired as independent Chair for personal reasons, with current director and finance expert Wendy Arlin assuming the Chair role and former Panera Brands CEO Niren Chaudhary joining the board as an independent director. This board reshaping brings together deep retail, consumer brands, and digital experience at the top of Kohl's governance structure, potentially influencing how the company tackles shifting shopping...

Halozyme Therapeutics (HALO) has drawn fresh attention after the stock reached a record high ahead of its upcoming earnings release, with investors watching how its patented drug delivery platform feeds into reported financials. See our latest analysis for Halozyme Therapeutics. The recent record high comes after a strong run, with Halozyme Therapeutics posting a 90 day share price return of 30.82% and a 1 year total shareholder return of 38.62%. The 3 year total shareholder return of 94.35%...

Five9 stock has staged a sharp rebound in the short term, yet the longer history is far harsher, which leaves the current valuation looking more like a reset than a clear bargain. Over the past 5 years, Five9 has delivered a share price decline of about 87%, which means long term holders have seen a very large erosion of capital that any new thesis now has to justify. Future revenue growth and progress toward stronger cash generation can support today’s price, while any sustained pressure on...

As you might know, Armstrong World Industries, Inc. ( NYSE:AWI ) just kicked off its latest second-quarter results with...

Verisk Analytics stock is coming off a year in which the share price fell 21.9%. The current valuation picture is mixed, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to about 17.1% upside, while traditional market multiples suggest the stock screens as expensive and the broader value checks are weak. Over the past 12 months, Verisk Analytics has declined 21.9%, which means recent returns have been difficult for shareholders despite a stronger short term bounce. The...

Baker Hughes (NasdaqGS:BKR) received an order from Dynamis Power Solutions for 76 NovaLT16 gas turbines and related power generation equipment. The turbines will support hypermobile data centers and oil and gas applications that require scalable, high-availability power. The agreement expands Baker Hughes' role in modular, mission-critical power projects serving both digital infrastructure and traditional energy customers. Baker Hughes operates across energy technology and services, and...

Leidos Holdings stock has fallen 37.7% year to date, yet its valuation checks and recent contract and product news are pointing investors back to the numbers on what they are paying for the business today. Year to date the share price is down 37.7%, which puts the recent rebound over the past month into context as a move happening after a sizeable pullback. New AI focused cybersecurity tools and recent defense contract wins can support sentiment on future revenue, while execution risk in...

Shareholders might have noticed that Expro Ltd ( NYSE:XPRO ) filed its quarterly result this time last week. The early...

Lennox International recently reported second-quarter 2026 results showing sales of US$1,545.3 million and net income of US$269 million, with broadly flat earnings per share while also announcing further share repurchases. Alongside these results, Lennox trimmed its full-year 2026 earnings guidance to US$23.00–US$24.00 per share but reaffirmed its approximately 8% revenue growth outlook, highlighting contrasting trends between weaker residential demand and stronger commercial...

On July 22, 2026, Casey's General Stores filed its definitive proxy statement urging shareholders to vote against a proposal to let investors owning at least 15% of outstanding shares call special shareholder meetings at the September 2, 2026 annual meeting. At the same time, analysts are watching for the company’s upcoming fiscal 2027 first-quarter earnings, where expectations of double-digit profit growth highlight the tension between governance debates and operational execution. We’ll now...

After a sharp 37.8% gain over the past month, WEX now sits near US$188, and the key issue for investors is that this strong share price move sits alongside valuation checks that lean more on the expensive side than on clear value. The 37.8% move over the past month puts recent momentum front and center, which can leave less room for error if expectations do not hold up. Growth in WEX's B2B payments and fleet fraud prevention offerings can support higher earnings expectations. However, any...

Energy infrastructure is back in focus after drone attacks at Egypt’s Damietta Port disrupted a key LNG hub and raised fresh questions about security near the Suez Canal. For investors, this kind of headline risk can quickly reshape how stocks exposed to LNG, pipelines, and shipping are priced, as the market weighs supply disruption, insurance costs, and geopolitical risk. This article looks at 3 stocks from an Energy Infrastructure & Security screener that appear more directly exposed to the...

Pinnacle Financial Partners (PNFP) is back in focus after reporting second quarter 2026 net income of US$328 million, compared to US$159 million a year earlier, alongside updated common and preferred dividend declarations. See our latest analysis for Pinnacle Financial Partners. The recent earnings and dividend updates have arrived against a backdrop of steady gains for Pinnacle Financial Partners, with the share price at US$104.74, a 7 day share price return of 7.58% and a 1 year total...

Teladoc Health stock is coming off a very weak 5 year run, yet current valuation checks and an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach both point to the shares screening as undervalued relative to those fundamentals. Teladoc Health has seen its share price decline 93.9% over the past 5 years, which puts long term returns sharply at odds with the current view that the stock may now be priced below its underlying value. The launch plans for the Teladoc One...